Themes ETF Trust Themes European Luxury ETF FINE 深 滬
已收盤 07-18 16:00:00 美东时间
22.35
+0.053
+0.24%
華盛通- 最 高22.35
- 今 開22.35
- 成交量 0股
- 最 低 22.35
- 昨 收 22.2971
- 總市值 67.05万
- 52周最高 25.005
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 17.78
- 委 比 0.00%
- 總股本 3.00万
- 歷史最高 26.1247
- 量 比 0
- 振 幅 0.00%
- 歷史最低 17.78
- 每 手 1
- 風險率 1.14%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多FINEOS Substantial Holder ECP Asset Management Reduces Stake
FINEOS Corporation Holdings Plc Shs Chess Depositary Interests Repr 1 Sh ( ($AU...
07-18 10:42
TENCENT MUSIC ENTERTAINMENT(1698.HK)2Q25 PREVIEW:SLIGHT PROFIT BEAT; STRENGTHENED REFINED OPERATIONS ON SOLIDIFIED KEY EDGES
We model 2Q25 12% YoY topline contributed by solid 19% YoY music, both meeting ...
07-16 12:07
Zepbound Powers Eli Lilly's Upbeat Q2 Outlook
BofA slightly raised Q2 estimates for Eli Lilly ahead of earnings as Zepbound sales improve; long-term forecasts for key drugs remain steady.
07-10 02:55
Bayer’s FINEROD Study: Real-World Insights on Finerenone’s Impact in CKD and T2D
Bayer AG (($BAYRY)), Bayer Ag (UK) (($GB:0P6S)) announced an update on their on...
07-04 00:21
Novo's India Move Could Reshape The Weight-Loss Drug War With Eli Lilly
Novo Nordisk launches Wegovy in India, pricing it close to Eli Lilly's Mounjaro, while advancing global regulatory efforts for its GLP-1 portfolio.
06-24 22:38
Novo Nordisk's Weight Loss Injection CagriSema Data Sparks Investor Concern
Novo Nordisk's CagriSema achieved significant weight loss in phase 3 trials, though safety concerns may limit its edge over existing and pipeline rivals.
06-23 21:10
FINEOS Corporation Announces New Company Secretary
FINEOS Corporation Holdings Plc Shs Chess Depositary Interests Repr 1 Sh ( ($AU...
06-20 08:17
“下一代减肥药”MariTide有望迎“双面突破”! 安进(AMGN.US)迈向价值重估之路
高盛维持对于安进股票的“买入”评级，同时予以目标价400美元，意味着在高盛分析师团队看来，安进未来12个月内股价较当前点位有约40%的上行潜力。
06-19 17:15
